Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04690348
Status:
RECRUITING
Last Update Posted:
2024-01-05
First Post:
2020-12-28
Brief Title:
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases a Randomized Phase II Study
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases a Randomized Phase II Study
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to see if Cs-131 brachytherapy is effective in people with recurrent brain cancer who are scheduled to have brain surgery for removal of their tumors The researchers would like to see whether Cs-131 prevents brain tumors from growing back after surgeryThe researchers will compare Cs-131 brachytherapy which occurs during brain surgery with the usual approach of brain surgery without brachytherapy The researchers will compare both the effectiveness and safety of the two approaches
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None